Chemistry: natural resins or derivatives; peptides or proteins; – Peptides of 3 to 100 amino acid residues – 11 to 14 amino acid residues in defined sequence
Reexamination Certificate
2006-09-26
2006-09-26
Andres, Janet L. (Department: 1649)
Chemistry: natural resins or derivatives; peptides or proteins;
Peptides of 3 to 100 amino acid residues
11 to 14 amino acid residues in defined sequence
C530S322000, C530S323000, C530S333000
Reexamination Certificate
active
07112654
ABSTRACT:
The present invention relates to compositions comprised of a peptide ligand or derivatives thereof that are capable of specific binding to the high affinity receptor-1 of vascular endothelial growth factor (VEGF) and structure similar receptors. The invention further provides a peptide ligand or derivatives thereof that are capable of inhibiting angiogenesis induced by VEGF. The present invention also provides a method for treatment or diagnosis of disease associated with angiogenesis in a patient in need of therapy comprising administering to the patient an effective amount of the pharmaceutical composition of the present invention and a pharmaceutical acceptable carrier.
REFERENCES:
patent: 6380370 (2002-04-01), Doucette-Stamm et al.
patent: 6733755 (2004-05-01), Tchistiakova et al.
patent: 0 882 799 (1998-12-01), None
patent: 1 086 956 (2001-03-01), None
patent: WO 89/01493 (1989-02-01), None
patent: WO 95/21868 (1995-08-01), None
patent: WO 00/55206 (2000-09-01), None
patent: WO 01/09157 (2001-02-01), None
Roselilde et al.. APMIS. 2004. 112: 481-95.
Iniguez et al. Trends in Mol. Med. 2003. 9:73-78.
Ecklin, D.J., et al., “Monoclonal Anti-Vascular Endothelial Growth Factor (VEGF) Receptor (KDR) Antibodies Which are Inhibitors of VEGF Binding and Antagonists of VEGF-Stimulated Signaling and Growth of Human Endothelial Cells”, AACR, 39:96 (Mar. 1998).
Iro, Nobuyuki, Journal of Biological Chemistry, 273:23410-23418 (1998).
Alakhov Valery
Li Shengmin
Pietrzynski Grzegorz
Tchistiakova Lioudmila
Gibbons Del Deo Dolan Griffinger & Vecchione
Supratek Pharma Inc.
Wang Chang-Yu
LandOfFree
Ligand for vascular endothelial growth factor receptor does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Ligand for vascular endothelial growth factor receptor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ligand for vascular endothelial growth factor receptor will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3544136